Personal information

Other IDs

Scopus Author ID: 56856742200

Countries

Italy

Activities

Collapse all

Employment (1)

San Raffaele Telethon Institute for Gene Therapy: Milano, Lombardia, IT

2019-09-01 to present
Employment
Source: Self-asserted source
Elena Barbon

Education and qualifications (4)

University of Ferrara: Ferrara, Emilia-Romagna, IT

2012-01-01 to 2015-03-27 | Research doctorate in Biochemistry, Molecular Biology and Biotechnology (Life Sciences and Biotechnology)
Education
Source: Self-asserted source
Elena Barbon

Généthon: Evry, Île-de-France, FR

2013-10-05 to 2014-09-31 | Internship
Education
Source: Self-asserted source
Elena Barbon

University of Ferrara: Ferrara, Emilia-Romagna, IT

2009-09-01 to 2011-07-13 | Master Degree in Biomolecular and Cellular Sciences
Education
Source: Self-asserted source
Elena Barbon

University of Ferrara: Ferrara, Emilia-Romagna, IT

2006-09-01 to 2009-07-16 | Bachelor Degree in Biotechnology (Medical Curriculum)
Education
Source: Self-asserted source
Elena Barbon

Works (16)

In vivo liver targeted genome editing as therapeutic approach: progresses and challenges

Frontiers in Genome Editing
2024-08-23 | Journal article
DOI: 10.3389/fgeed.2024.1458037
Part of ISSN: 2673-3439
Contributors: Chiara Simoni; Elena Barbon; Andrés F. Muro; Alessio Cantore
Source: Self-asserted source
Elena Barbon

Pathological modeling of glycogen storage disease type III with CRISPR/Cas9 edited human pluripotent stem cells

Frontiers in Cell and Developmental Biology
2023-05-11 | Journal article
DOI: 10.3389/fcell.2023.1163427
Part of ISSN: 2296-634X
Contributors: Lucille Rossiaud; Pascal Fragner; Elena Barbon; Antoine Gardin; Manon Benabides; Emilie Pellier; Jérémie Cosette; Lina El Kassar; Karine Giraud-Triboult; Xavier Nissan et al.
Source: Self-asserted source
Elena Barbon
grade
Preferred source (of 3)‎

Development of a dual hybrid AAV vector for endothelial-targeted expression of von Willebrand factor

Gene Therapy
2023-04 | Journal article
DOI: 10.1038/s41434-020-00218-6
Contributors: Elena Barbon; Charlotte Kawecki; Solenne Marmier; Aboud Sakkal; Fanny Collaud; Severine Charles; Giuseppe Ronzitti; Caterina Casari; Olivier D. Christophe; Cécile V. Denis et al.
Source: check_circle
Crossref

Illustrated State‐of‐the‐Art Capsules of the ISTH 2022 Congress

Research and Practice in Thrombosis and Haemostasis
2022-07 | Journal article
DOI: 10.1002/rth2.12747
Part of ISSN: 2475-0379
Contributors: Robert A. Ariëns; Beverley J. Hunt; Ejaife O. Agbani; Josefin Ahnström; Robert Ahrends; Raza Alikhan; Alice Assinger; Zsuzsa Bagoly; Alessandra Balduini; Elena Barbon et al.
Source: Self-asserted source
Elena Barbon

Promoterless Gene Targeting Approach Combined to CRISPR/Cas9 Efficiently Corrects Hemophilia B Phenotype in Neonatal Mice

Frontiers in Genome Editing
2022-03-11 | Journal article
DOI: 10.3389/fgeed.2022.785698
Part of ISSN: 2673-3439
Contributors: Michela Lisjak; Alessia De Caneva; Thibaut Marais; Elena Barbon; Maria Grazia Biferi; Fabiola Porro; Adi Barzel; Lorena Zentilin; Mark A. Kay; Federico Mingozzi et al.
Source: Self-asserted source
Elena Barbon

IgG-cleaving endopeptidase enables in vivo gene therapy in the presence of anti-AAV neutralizing antibodies

Nature Medicine
2020-07 | Journal article
DOI: 10.1038/s41591-020-0911-7
Part of ISSN: 1078-8956
Part of ISSN: 1546-170X
Contributors: Christian Leborgne; Elena Barbon; Jeffrey Alexander; Hayley Hanby; Sandrine Delignat; Daniel Cohen; Fanny Collaud; Saghana Muraleetharan; Dan Lupo; Joseph Silverberg et al.
Source: Self-asserted source
Elena Barbon

Single‐domain antibodies targeting antithrombin reduce bleeding in hemophilic mice with or without inhibitors

EMBO Molecular Medicine
2020-04-07 | Journal article
DOI: 10.15252/emmm.201911298
Contributors: Elena Barbon; Gabriel Ayme; Amel Mohamadi; Jean‐François Ottavi; Charlotte Kawecki; Caterina Casari; Sebastien Verhenne; Solenne Marmier; Laetitia van Wittenberghe; Severine Charles et al.
Source: check_circle
Crossref

Recombinant Adeno-Associated Viral Vectors Expressing Human Coagulation FIX-E456H Variant in Hemophilia B Mice.

Thrombosis and haemostasis
2019-10 | Journal article
PMID: 31659733
Contributors: Le Quellec S; Dane AP; Barbon E; Bordet JC; Mingozzi F; Dargaud Y; Marais T; Biferi MG; Négrier C; Nathawani AC et al.
Source: Self-asserted source
Elena Barbon via Europe PubMed Central

Tailoring the CRISPR system to transactivate coagulation gene promoters in normal and mutated contexts.

Biochimica et biophysica acta. Gene regulatory mechanisms
2019-04 | Journal article
PMID: 31005673
Contributors: Pignani S; Zappaterra F; Barbon E; Follenzi A; Bovolenta M; Bernardi F; Branchini A; Pinotti M
Source: Self-asserted source
Elena Barbon via Europe PubMed Central

Exon-specific U1 snRNAs improve ELP1 exon 20 definition and rescue ELP1 protein expression in a familial dysautonomia mouse model.

Human molecular genetics
2018-07 | Journal article
PMID: 29701768
PMC: PMC6030917
Contributors: Donadon I; Pinotti M; Rajkowska K; Pianigiani G; Barbon E; Morini E; Motaln H; Rogelj B; Mingozzi F; Slaugenhaupt SA et al.
Source: Self-asserted source
Elena Barbon via Europe PubMed Central

Influence of Pre-existing Anti-capsid Neutralizing and Binding Antibodies on AAV Vector Transduction.

Molecular therapy. Methods & clinical development
2018-02 | Journal article
PMID: 29766022
PMC: PMC5948224
Contributors: Fitzpatrick Z; Leborgne C; Barbon E; Masat E; Ronzitti G; van Wittenberghe L; Vignaud A; Collaud F; Charles S; Simon Sola M et al.
Source: Self-asserted source
Elena Barbon via Europe PubMed Central

Correction of the Exon 2 Duplication in DMD Myoblasts by a Single CRISPR/Cas9 System.

Molecular therapy. Nucleic acids
2017-02 | Journal article
PMID: 28624187
PMC: PMC5363679
Contributors: Lattanzi A; Duguez S; Moiani A; Izmiryan A; Barbon E; Martin S; Mamchaoui K; Mouly V; Bernardi F; Mavilio F et al.
Source: Self-asserted source
Elena Barbon via Europe PubMed Central

Transposon-mediated Generation of Cellular and Mouse Models of Splicing Mutations to Assess the Efficacy of snRNA-based Therapeutics.

2016-11 | Journal article
DOI: 10.1038/mtna.2016.97
PMID: 27898092
PMC: PMC5155329
Contributors: Barbon E; Ferrarese M; van Wittenberghe L; Sanatine P; Ronzitti G; Collaud F; Colella P; Pinotti M; Mingozzi F
Source: Self-asserted source
Elena Barbon via Europe PubMed Central

An engineered tale-transcription factor rescues transcription of factor VII impaired by promoter mutations and enhances its endogenous expression in hepatocytes.

2016-06 | Journal article
DOI: 10.1038/srep28304
PMID: 27341548
PMC: PMC4920032
Contributors: Barbon E; Pignani S; Branchini A; Bernardi F; Pinotti M; Bovolenta M
Source: Self-asserted source
Elena Barbon via Europe PubMed Central

Molecular Basis and Therapeutic Strategies to Rescue Factor IX Variants That Affect Splicing and Protein Function.

2016-05 | Journal article
DOI: 10.1371/journal.pgen.1006082
PMID: 27227676
PMC: PMC4882169
Contributors: Tajnik M; Rogalska ME; Bussani E; Barbon E; Balestra D; Pinotti M; Pagani F
Source: Self-asserted source
Elena Barbon via Europe PubMed Central

Regulation of a strong F9 cryptic 5'ss by intrinsic elements and by combination of tailored U1snRNAs with antisense oligonucleotides

Human Molecular Genetics
2015 | Journal article
DOI: 10.1093/hmg/ddv205
EID:

2-s2.0-84941914961
Contributors: Balestra, D.; Barbon, E.; Scalet, D.; Cavallari, N.; Perrone, D.; Zanibellato, S.; Bernardi, F.; Pinotti, M.
Source: Self-asserted source
Elena Barbon via Scopus - Elsevier
How many people are using ORCID?